This drug in a first in class and world first will change the Brain injury and Heart protection space forever. Clearing safety in humans. Will be taken over that’s for sure. Rubbish 20 million market cap and should be a 60-120 million market cap like peers in this space on safety but difference is has larger potential and market potential
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Dosing Update No 1
NYR
nyrada inc.
Add to My Watchlist
10.2%
!
22.0¢

Ann: Phase I Clinical Trial Dosing Update No 1, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.0¢ |
Change
-0.025(10.2%) |
Mkt cap ! $46.40M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 22.0¢ | $256.0K | 1.085M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67420 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25083 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 67420 | 0.220 |
1 | 100000 | 0.215 |
2 | 50000 | 0.210 |
1 | 50000 | 0.205 |
4 | 121224 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25083 | 2 |
0.235 | 106360 | 1 |
0.245 | 100000 | 1 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |